CAPER, a novel regulator of human breast cancer progression-Reference-Cited by-同舟云学术

CAPER, a novel regulator of human breast cancer progression

Published:2014-02-17 Issue:8 Volume:13 Page:1256-1264
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Mercier Isabelle,Gonzales Donna M,Quann Kevin,Pestell Timothy G,Molchansky Alexander,Sotgia Federica,Hulit James,Gandara Ricardo,Wang Chenguang,Pestell Richard G,Lisanti Michael P,Jasmin Jean-François

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.28156

Reference54 articles.

1. Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

2. Therapeutic potential of selective estrogen receptor modulators

3. Estrogen Receptors: How Do They Signal and What Are Their Targets

4. Estrogen and the Risk of Breast Cancer

5. Epidemiology and Prevention of Breast Cancer

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in anticancer mechanisms of molecular glue degraders: focus on RBM39-dgrading synthetic sulfonamide such as indisulam, E7820, tasisulam, and chloroquinoxaline sulfonamide;Genes & Genomics;2024-09-13

2. Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia;Journal of Experimental & Clinical Cancer Research;2024-07-24

3. Indisulam synergizes with melphalan to inhibit Multiple Myeloma malignancy via targeting TOP2A;PLOS ONE;2024-04-09

4. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma;Translational Cancer Research;2024-04

5. Inflammation as a driver of hematological malignancies;Frontiers in Oncology;2024-03-20